Skyline Ventures logo

Skyline Ventures

North America, California, United States, Palo Alto

Description

Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in investing in outstanding product-focused

Investor Profile

Skyline Ventures has made 76 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series B (30%)
  • Series A (17%)
  • Series Unknown (16%)
  • Series C (16%)
  • Series D (13%)
  • Series E (3%)
  • Post Ipo Debt (3%)
  • Private Equity (1%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device
  • Therapeutics
  • Genetics
  • Health Diagnostics
  • Hospital
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Skyline Ventures frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 7
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 6
Domain Associates
North America, California, United States, San Diego
Co-Investments: 7
TVM Capital
Europe, Bayern, Germany, Munich
Co-Investments: 11
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 9
Three Arch Partners
North America, California, United States, Portola Valley
Co-Investments: 11
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 10
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 7
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 8
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 7

Which angels does Skyline Ventures often collaborate with?

AZ
North America, California, United States, Mountain View
Shared Deals: 1
TF
North America, California, United States, San Jose
Shared Deals: 1

What are some of recent deals done by Skyline Ventures?

Sutro Biopharma

South San Francisco, California, United States

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

BiotechnologyInformation TechnologyMedical
Series EJul 26, 2018
Amount Raised: $85,400,000
Dicerna Pharmaceuticals

Lexington, Massachusetts, United States

Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.

BiotechnologyGeneticsHealth CarePharmaceutical
Post Ipo DebtMar 30, 2017
Amount Raised: $70,000,000
SI-BONE

San Jose, California, United States

SI-BONE advances the diagnostic understanding of lower back pain and minimally invasive surgery for the sacroiliac joint.

Health CareHealth DiagnosticsHospital
Series UnknownJun 17, 2016
Amount Raised: $26,000,000
SI-BONE

San Jose, California, United States

SI-BONE advances the diagnostic understanding of lower back pain and minimally invasive surgery for the sacroiliac joint.

Health CareHealth DiagnosticsHospital
Series UnknownMay 26, 2015
Amount Raised: $21,000,000
Collegium Pharmaceutical

Stoughton, Massachusetts, United States

Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain.

BiotechnologyLife ScienceMedicalTherapeutics
Private EquityMar 10, 2015
Amount Raised: $50,000,000
Proteon Therapeutics

Waltham, Massachusetts, United States

Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.

BiotechnologyMedicalPharmaceutical
Series DMay 16, 2014
Amount Raised: $45,000,000
SI-BONE

San Jose, California, United States

SI-BONE advances the diagnostic understanding of lower back pain and minimally invasive surgery for the sacroiliac joint.

Health CareHealth DiagnosticsHospital
Series UnknownApr 28, 2014
Amount Raised: $33,000,000
Sutro Biopharma

South San Francisco, California, United States

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

BiotechnologyInformation TechnologyMedical
Series DDec 11, 2013
Amount Raised: $26,000,000
Dicerna Pharmaceuticals

Lexington, Massachusetts, United States

Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.

BiotechnologyGeneticsHealth CarePharmaceutical
Series CJul 31, 2013
Amount Raised: $60,000,000
Crescendo Bioscience

South San Francisco, California, United States

Crescendo Bioscience develops diagnostic tools to provide rheumatologists with clinical insights to autoimmune and inflammatory disease.

BiotechnologyHealth CareMedical
Series DJan 3, 2013
Amount Raised: $28,000,000